Talvey 40mg/1ml injection (Talquetamab Vials) 40mg/1ml

Talvey 40mg/1ml injection contains talquetamab, a prescription medication supplied in single-use vials. This formulation is designed for subcutaneous administration under medical supervision. Store between 2–8°C to maintain potency. Always follow healthcare provider instructions when using this product.

Strength

40mg/1ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Janssen-Cilag Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talvey 40mg/1ml injection is used to treat relapsed or refractory multiple myeloma in adults who have received prior therapies. It helps manage cancer of plasma cells by targeting specific proteins. This medication is prescribed when other treatments have not been effective. It is given as part of a broader treatment plan.

Side Effects

Common effects may include reactions at the injection site, fatigue, or changes in blood cell counts. Some users report mild to moderate immune-related responses during treatment. These effects vary by individual and should be monitored by a healthcare professional.

Precautions & Warnings

Keep Talvey 40mg/1ml injection refrigerated and protect from light until use. Do not freeze or shake the vial. Use within the specified time after opening as directed. Dispose of used vials and supplies properly to avoid contamination. Always check expiration dates before administration.

Avoid Interactions

Talvey 40mg/1ml injection may interact with other medications that affect the immune system, such as corticosteroids or immunosuppressants. Avoid live vaccines during treatment unless approved by a doctor. Discuss all current medications with your healthcare provider before starting this therapy.

Frequently Asked Questions

Talquetamab is used to treat relapsed or refractory multiple myeloma in adults who have tried other therapies.

It is administered as a subcutaneous injection by a healthcare professional, typically in a clinical setting.

Common effects may include injection site reactions, fatigue, or changes in blood cell counts.

No, it must be stored between 2–8°C and protected from light until use.

Talquetamab helps manage multiple myeloma but is not a cure; it is part of ongoing treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.